GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 295 filers reported holding GUARDANT HEALTH INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $223,392 | -33.5% | 6,240 | 0.0% | 0.02% | -41.4% |
| Q3 2022 | $336,000 | +33.3% | 6,240 | 0.0% | 0.03% | +45.0% |
| Q2 2022 | $252,000 | -39.0% | 6,240 | 0.0% | 0.02% | -28.6% |
| Q1 2022 | $413,000 | -33.8% | 6,240 | 0.0% | 0.03% | -31.7% |
| Q4 2021 | $624,000 | -20.0% | 6,240 | 0.0% | 0.04% | -26.8% |
| Q3 2021 | $780,000 | +0.6% | 6,240 | 0.0% | 0.06% | 0.0% |
| Q2 2021 | $775,000 | -18.7% | 6,240 | 0.0% | 0.06% | -24.3% |
| Q1 2021 | $953,000 | +18.5% | 6,240 | 0.0% | 0.07% | +10.4% |
| Q4 2020 | $804,000 | +15.2% | 6,240 | 0.0% | 0.07% | +3.1% |
| Q3 2020 | $698,000 | +37.9% | 6,240 | 0.0% | 0.06% | +25.0% |
| Q2 2020 | $506,000 | +16.6% | 6,240 | 0.0% | 0.05% | 0.0% |
| Q1 2020 | $434,000 | -11.1% | 6,240 | 0.0% | 0.05% | +10.6% |
| Q4 2019 | $488,000 | +22.6% | 6,240 | 0.0% | 0.05% | +14.6% |
| Q3 2019 | $398,000 | -26.2% | 6,240 | 0.0% | 0.04% | -26.8% |
| Q2 2019 | $539,000 | – | 6,240 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |